Actemra IV/Sub-Q
Actemra (tocilizumab) is an interleukin-6 (IL-6) receptor inhibitor used to treat moderate to severe rheumatoid arthritis in children and adults.
Actemra (tocilizumab) is an interleukin-6 (IL-6) receptor inhibitor used to treat moderate to severe rheumatoid arthritis in children and adults.
Weighing in
Your ACTEMRA IV infusion dose is based on your weight, so before every infusion you’ll be weighed. If your weight changes, you and your healthcare provider will decide if a change in dose is necessary.
During your IV infusion
Monitoring
A healthcare provider or nurse should always be on hand during your ACTEMRA IV infusion to monitor you and to respond to any reactions and answer any questions you may have. It’s important to pay close attention to how you’re feeling during and after an IV infusion. ACTEMRA may lead to serious allergic reactions, including death, that may happen even if they have not happened before. Let your healthcare provider or nurse know if you’re experiencing:
After your IV infusion
Note how you’re feeling after each ACTEMRA IV infusion. Tell your healthcare provider or nurse right away if you’re experiencing any reactions during or after treatment.
Common side effects of Actemra include:
Tell your doctor if you have serious side effects of Actemra including: